Ann: MedAdvisor $9.5m Investment from EBOS, page-7

  1. 1,864 Posts.
    lightbulb Created with Sketch. 80
    To formalise the relationship, the parties have initially concluded in principal commercial agreements that expand the relationship with TerryWhite Chemmart and form a new relationship with each of HPS and Zest from EBOS’ Institutional Healthcare division. MedAdvisor estimates that over 3 years, these arrangements will generate ~$4m of revenue.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.1¢
Change
0.002(2.53%)
Mkt cap ! $50.60M
Open High Low Value Volume
7.8¢ 8.1¢ 7.7¢ $137.0K 1.729M

Buyers (Bids)

No. Vol. Price($)
1 154951 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 32040 1
View Market Depth
Last trade - 15.54pm 27/06/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.